Nathan Pennell MD, PhD, FASCO
@n8pennell.bsky.social
Thoracic oncologist. Dad, dogs and cats living together, Steeler and Tarheel fan. Personal account, all opinions mine. #Medsky #LCSM #Oncsky
Pinned
After 17 years at Cleveland Clinic I am starting today as Senior Vice President and Worldwide Head of Hematology and Oncology Medical Affairs at Bristol-Myers Squibb. I am so thankful to all my colleagues, friends, and patients at the Clinic and will be forever grateful for my experiences there.
After 17 years at Cleveland Clinic I am starting today as Senior Vice President and Worldwide Head of Hematology and Oncology Medical Affairs at Bristol-Myers Squibb. I am so thankful to all my colleagues, friends, and patients at the Clinic and will be forever grateful for my experiences there.
August 18, 2025 at 11:52 AM
After 17 years at Cleveland Clinic I am starting today as Senior Vice President and Worldwide Head of Hematology and Oncology Medical Affairs at Bristol-Myers Squibb. I am so thankful to all my colleagues, friends, and patients at the Clinic and will be forever grateful for my experiences there.
Reposted by Nathan Pennell MD, PhD, FASCO
I spoke with NPR about the threatening letters that the Republican administration is sending to medical journals.
May 4, 2025 at 6:17 AM
I spoke with NPR about the threatening letters that the Republican administration is sending to medical journals.
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.... #ASCO25 @drbonillaonc.bsky.social
May 2, 2025 at 8:02 PM
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.... #ASCO25 @drbonillaonc.bsky.social
Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer | JCO Precision Oncology ascopubs.org/doi/10.1200/...
Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer | JCO Precision Oncology
PURPOSENeurotrophic tyrosine receptor kinase gene fusions are oncogenic drivers of various
solid tumors. Larotrectinib is a highly selective tropomyosin receptor kinase (TRK)
inhibitor approved for pa...
ascopubs.org
April 25, 2025 at 12:26 PM
Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer | JCO Precision Oncology ascopubs.org/doi/10.1200/...
Reposted by Nathan Pennell MD, PhD, FASCO
New podcast worth your time: ASCO Education: By the Book
@n8pennell.bsky.social and @drdonsdizon.bsky.social and explores the key issues shaping the future of cancer care.
An insightful listen for anyone in #oncology, #meded, or #cancerresearch.
🔗 buff.ly/WPfU6Nk
@n8pennell.bsky.social and @drdonsdizon.bsky.social and explores the key issues shaping the future of cancer care.
An insightful listen for anyone in #oncology, #meded, or #cancerresearch.
🔗 buff.ly/WPfU6Nk
ASCO Education: The Evolution of the ASCO Educational Book and the Issues Shaping the Future of Oncology
On the inaugural episode of ASCO Education: By the Book, Dr. Nathan Pennell and Dr. Don Dizon share reflections on the evolution of the ASCO Educational Book, its global reach, and the role of its…
buff.ly
April 15, 2025 at 2:05 PM
New podcast worth your time: ASCO Education: By the Book
@n8pennell.bsky.social and @drdonsdizon.bsky.social and explores the key issues shaping the future of cancer care.
An insightful listen for anyone in #oncology, #meded, or #cancerresearch.
🔗 buff.ly/WPfU6Nk
@n8pennell.bsky.social and @drdonsdizon.bsky.social and explores the key issues shaping the future of cancer care.
An insightful listen for anyone in #oncology, #meded, or #cancerresearch.
🔗 buff.ly/WPfU6Nk
So excited to kick off the first episode of our new podcast: ASCO Education: By the Book with good friend and former #EdBook editor @drdonsdizon.bsky.social!
@ascocancer.bsky.social ascoeducation.libsyn.com/the-evolutio...
@ascocancer.bsky.social ascoeducation.libsyn.com/the-evolutio...
ASCO Education: The Evolution of the ASCO Educational Book and the Issues Shaping the Future of Oncology
On the inaugural episode of ASCO Education: By the Book, Dr. Nathan Pennell and Dr. Don Dizon share reflections on the evolution of the ASCO Educational Book, its global reach, and the role of its new...
ascoeducation.libsyn.com
April 14, 2025 at 2:46 PM
So excited to kick off the first episode of our new podcast: ASCO Education: By the Book with good friend and former #EdBook editor @drdonsdizon.bsky.social!
@ascocancer.bsky.social ascoeducation.libsyn.com/the-evolutio...
@ascocancer.bsky.social ascoeducation.libsyn.com/the-evolutio...
Reposted by Nathan Pennell MD, PhD, FASCO
Taletrectinib in ROS1+ Non–Small Cell Lung Cancer: TRUST | Journal of Clinical Oncology ascopubs.org/doi/10.1200/... @n8pennell.bsky.social @ascocancer.bsky.social @oncoalert.bsky.social
April 5, 2025 at 7:20 PM
Taletrectinib in ROS1+ Non–Small Cell Lung Cancer: TRUST | Journal of Clinical Oncology ascopubs.org/doi/10.1200/... @n8pennell.bsky.social @ascocancer.bsky.social @oncoalert.bsky.social
Enhancing Sexual Health for Cancer Survivors | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.... @ascocancer.bsky.social
Enhancing Sexual Health for Cancer Survivors
Changes to sexual function after cancer treatment are extremely prevalent, affecting
up to 90% of female patients with cancer and 40%-85% of male patients with cancer.
Sexual health concerns include l...
ascopubs.org
April 5, 2025 at 2:42 PM
Enhancing Sexual Health for Cancer Survivors | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.... @ascocancer.bsky.social
Reposted by Nathan Pennell MD, PhD, FASCO
Want to shape the future of oncology news & education? The ASCO #EdBook is seeking an Editor-in-Chief to lead our team. Apply now and make a difference: brnw.ch/21wRfD8
#oncsky
#oncsky
March 11, 2025 at 3:00 PM
Want to shape the future of oncology news & education? The ASCO #EdBook is seeking an Editor-in-Chief to lead our team. Apply now and make a difference: brnw.ch/21wRfD8
#oncsky
#oncsky
Reposted by Nathan Pennell MD, PhD, FASCO
The Trump administration blocked key parts of the federal government’s apparatus for funding biomedical research, effectively halting progress on much of the country’s future work on illnesses like cancer despite a federal judge’s order to release grant money. www.nytimes.com/2025/02/21/s...
Trump Administration Stalls Scientific Research Despite Court Ruling (Gift Article)
Using an arcane law, officials have effectively delayed funding from the National Institutes of Health, leaving medical studies in jeopardy.
www.nytimes.com
February 22, 2025 at 1:49 PM
The Trump administration blocked key parts of the federal government’s apparatus for funding biomedical research, effectively halting progress on much of the country’s future work on illnesses like cancer despite a federal judge’s order to release grant money. www.nytimes.com/2025/02/21/s...
Reposted by Nathan Pennell MD, PhD, FASCO
Packed room at #TTLC25 and fantastic intro talk to EGFR therapy sequencing and unanswered questions by my colleague Dr Julia Rotow
#lcsm #oncsky @danafarber.bsky.social @iaslc.bsky.social
#lcsm #oncsky @danafarber.bsky.social @iaslc.bsky.social
February 20, 2025 at 4:33 PM
Packed room at #TTLC25 and fantastic intro talk to EGFR therapy sequencing and unanswered questions by my colleague Dr Julia Rotow
#lcsm #oncsky @danafarber.bsky.social @iaslc.bsky.social
#lcsm #oncsky @danafarber.bsky.social @iaslc.bsky.social
Reposted by Nathan Pennell MD, PhD, FASCO
Medicare Advantage beneficiaries who are suing UnitedHealth Group over allegedly wrongful denials of care that were based on artificial intelligence scored a victory Thursday.
Judge rules lawsuit over UnitedHealth’s AI care denials can move forward
Medicare Advantage beneficiaries who are suing UnitedHealth Group over allegedly wrongful denials of care that were based on artificial intelligence scored a victory Thursday.
buff.ly
February 14, 2025 at 12:13 AM
Medicare Advantage beneficiaries who are suing UnitedHealth Group over allegedly wrongful denials of care that were based on artificial intelligence scored a victory Thursday.
Did someone leave Little Debbie valentine snack cakes in the workroom of uncertain provenance and age? And did I eat them? I’ll never tell!
February 13, 2025 at 1:32 PM
Did someone leave Little Debbie valentine snack cakes in the workroom of uncertain provenance and age? And did I eat them? I’ll never tell!
Reposted by Nathan Pennell MD, PhD, FASCO
Promoting Reasonable Career Expectations + Maximizing Professional Fulfillment for Academic Oncologists @ascocancer.bsky.social Recs for Academic Med Ctrs ascopubs.org/doi/full/10....
@ahahospitals.bsky.social @aacicancer.bsky.social @cancerletter.com @aamctoday.bsky.social
@oncoalert.bsky.social
@ahahospitals.bsky.social @aacicancer.bsky.social @cancerletter.com @aamctoday.bsky.social
@oncoalert.bsky.social
https://ascopubs.org/doi/full/10.12…
February 12, 2025 at 12:59 AM
Promoting Reasonable Career Expectations + Maximizing Professional Fulfillment for Academic Oncologists @ascocancer.bsky.social Recs for Academic Med Ctrs ascopubs.org/doi/full/10....
@ahahospitals.bsky.social @aacicancer.bsky.social @cancerletter.com @aamctoday.bsky.social
@oncoalert.bsky.social
@ahahospitals.bsky.social @aacicancer.bsky.social @cancerletter.com @aamctoday.bsky.social
@oncoalert.bsky.social
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers ascopubs.org/doi/10.1200/...
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers
In this statement, ASCO encourages academic medical centers to change their policies
and expectations to enhance and promote the professional fulfillment of academic medical
oncologists. The statement...
ascopubs.org
February 11, 2025 at 2:33 AM
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers ascopubs.org/doi/10.1200/...
Reposted by Nathan Pennell MD, PhD, FASCO
Thanks to @jamessmurphy.bsky.social you can see about how much funding your state will lose each year from NIH indirect funding caps.
In Ohio, it amounts to over $170 Million annually just from the loss of indirect costs.
datawrapper.dwcdn.net/l0ZqA/9/
In Ohio, it amounts to over $170 Million annually just from the loss of indirect costs.
datawrapper.dwcdn.net/l0ZqA/9/
February 9, 2025 at 10:00 PM
Thanks to @jamessmurphy.bsky.social you can see about how much funding your state will lose each year from NIH indirect funding caps.
In Ohio, it amounts to over $170 Million annually just from the loss of indirect costs.
datawrapper.dwcdn.net/l0ZqA/9/
In Ohio, it amounts to over $170 Million annually just from the loss of indirect costs.
datawrapper.dwcdn.net/l0ZqA/9/
Reposted by Nathan Pennell MD, PhD, FASCO
Last year the spaces for our ALK Summit were filled in just 5 days. We've got another great line up planned this year. Encourage our patient and caregiver community to register now. Link below 👇
🌟2025 ALK+ Summit registration is now open!🌟
Join us in beautiful San Diego, CA, July 18-20 to connect with your ALK community and hear the latest updates in research and treatment options. Last year's summit reached capacity quickly—sign up now to secure your spot! secure.qgiv.com/for/alksummi...
Join us in beautiful San Diego, CA, July 18-20 to connect with your ALK community and hear the latest updates in research and treatment options. Last year's summit reached capacity quickly—sign up now to secure your spot! secure.qgiv.com/for/alksummi...
ALK+ Summit 2025
secure.qgiv.com
February 7, 2025 at 11:14 AM
Last year the spaces for our ALK Summit were filled in just 5 days. We've got another great line up planned this year. Encourage our patient and caregiver community to register now. Link below 👇
Reposted by Nathan Pennell MD, PhD, FASCO
Reposted by Nathan Pennell MD, PhD, FASCO
1. Today the NIH director issued a new directive slashing overhead rates to 15%.
I want to provide some context on what that means and why it matters.
grants.nih.gov/grants/guide...
I want to provide some context on what that means and why it matters.
grants.nih.gov/grants/guide...
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
grants.nih.gov
February 8, 2025 at 12:18 AM
1. Today the NIH director issued a new directive slashing overhead rates to 15%.
I want to provide some context on what that means and why it matters.
grants.nih.gov/grants/guide...
I want to provide some context on what that means and why it matters.
grants.nih.gov/grants/guide...
Reposted by Nathan Pennell MD, PhD, FASCO
Vaccines do not cause autism. You’ve heard that before, but it's often repeated without an explanation of how we know that. Here's the explanation.
Here is how we know that vaccines do not cause autism
Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know it to be true. Here's how we know.
buff.ly
February 3, 2025 at 9:01 PM
Vaccines do not cause autism. You’ve heard that before, but it's often repeated without an explanation of how we know that. Here's the explanation.
Reposted by Nathan Pennell MD, PhD, FASCO
Reposted by Nathan Pennell MD, PhD, FASCO
In case your missed something at #ASCO #GI25, check out the coverage in #ASCODailyNews dailynews.ascopubs.org
ASCO Daily News
dailynews.ascopubs.org
January 25, 2025 at 10:27 PM
In case your missed something at #ASCO #GI25, check out the coverage in #ASCODailyNews dailynews.ascopubs.org
Reposted by Nathan Pennell MD, PhD, FASCO
Speaking of healthcare. Let's make @bsky.app the platform that fights misinformation. Some great follows are @drsusanoliver.bsky.social @jsm2334.bsky.social @therealtruther.bsky.social
Let's get them more followers and engagement than other platforms and let health science accounts find a home
Let's get them more followers and engagement than other platforms and let health science accounts find a home
January 25, 2025 at 10:52 PM